Rheolytic Pharmacomechanical Thrombectomy in Renal Dialysis Arteriovenous Fistula and Graft Thrombosis: Outcomes from a Tertiary Hospital in Qatar

Abstract

Purpose To investigate the ability to salvage an acutely thrombosed dialysis access using rheolytic pharmacomechanical thrombectomy (PMT), the short- and medium-term patency rates and safety at a tertiary care hospital.

Methods A retrospective review of all patients who underwent rheolytic PMT for a thrombosed arteriovenous fistula (AVF) or arteriovenous graft (AVG) from October 2020 to 2023 was performed. Primary patency was defined as the ability to successfully dialyze through the treated access site without further intervention. Secondary patency included patients who required additional interventions that enabled them to continue dialysis. Data analysis was conducted using SPSS for comprehensive statistical evaluation.

Results A total of 37 thrombectomy procedures, involving 15 AVF and 22 AVG cases, were performed on 31 patients; 20 males and 11 females with a mean age of 62 ± 13 years. The average time from recognizing dialysis access site dysfunction to intervention was 2.6 ± 1.4 days. The mean total rheolytic PMT run time was 295 ± 119 seconds. Immediate technical success was defined as restoration of flow between the arteriovenous anastomosis and the central veins. Technical success was achieved in 91.9% (34/37) of thrombectomies. Clinical success was defined as the ability to achieve successful dialysis within 48 hours of the intervention. In total, 72.9% (27/37) of these cases achieved clinical success. Primary patency rates at 1, 3, and 6 months were 87.5, 78, and 46.9%, respectively. Secondary patency rates at 3, 6, and 12 months were 87.5, 66.7, and 58.3%, respectively. Angioplasty was performed in all procedures, and stent insertion was required in 13.5% (5/37) of thrombectomies.

Conclusion This study adds to the evidence that rheolytic PMT is a safe and effective tool for AVF and AVG salvage. After an initial thrombosis, the chance of re-thrombosis within 12 to 24 months is high and teams looking after these patients should have a strategy for future dialysis access.

Keywords

arteriovenous fistula - arteriovenous graft - thrombectomy

Publikationsverlauf

Artikel online veröffentlicht:
20. Dezember 2024

• References

• 1 Ghonimi TA, Hamad A, Iqbal Z. et al. Mortality of dialysis patients in Qatar: a retrospective epidemiologic study. Qatar Med J 2021; 2021 (01) 02
• 2 Vachharajani T, Jasuja S, AlSahow A. et al. Current status and future of end-stage kidney disease in Gulf Cooperation Council countries: challenges and opportunities. Saudi J Kidney Dis Transpl 2021; 32 (04) 1073-1088
• 3 Valji K, Bookstein JJ, Roberts AC, Davis GB. Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: early and late clinical results. Radiology 1991; 178 (01) 243-247
• 4 Chan PG, Goh GS. Safety and efficacy of the AngioJet device in the treatment of thrombosed arteriovenous fistula and grafts: a systematic review. J Vasc Access 2018; 19 (03) 243-251
• 5 Gray RJ, Sacks D, Martin LG, Trerotola SO. Society of Interventional Radiology Technology Assessment Committee. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol 2003; 14 (9, Pt 2): S433-S442
• 6 Access V. Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48 (Suppl. 01) S176-S247
• 7 Qatar National Planning Council [Internet]. Monthly figures on total population. Accessed October 25, 2024 at: https://www.psa.gov.qa/en/statistics1/StatisticsSite/Pages/Population.aspx
• 8 Littler P, Cullen N, Gould D, Bakran A, Powell S. AngioJet thrombectomy for occluded dialysis fistulae: outcome data. Cardiovasc Intervent Radiol 2009; 32 (02) 265-270
• 9 Drouven JW, de Bruin C, van Roon AM, Oldenziel J, Bokkers RPH, Zeebregts CJ. Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes. Catheter Cardiovasc Interv 2020; 95 (04) 758-764
• 10 Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001; 12 (02) 179-185